Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Garrett

Showing results (241-250 of 330) with videos related to

Pageof 33
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Pharmacodynamic-guided modified continuous reassessment method-based, dose-finding study of rapamycin in adult patients with solid tumorsAntonio Jimeno, Michelle A Rudek, Peter Kulesza, et al.
Pigment Cell & Melanoma Research|July 17, 2018
Molecular properties of gp100-reactive T-cell receptors drive the cytokine profile and antitumor efficacy of transgenic host T cellsJonathan M Eby, Angela R Smith, Timothy P Riley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2025
Promoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists: ASCO Recommendations for Academic Medical CentersEric P Winer, Laura A Levit, Ethan Basch, et al.
JCO Oncology Advances|February 5, 2025
State of Professional Well-Being, Satisfaction, and Career Plans Among US Oncologists in 2023Caroline Schenkel, Laura A Levit, Kelsey Kirkwood, et al.
Cancer Research|August 29, 2014
Promoting thiol expression increases the durability of antitumor T-cell functionsPravin Kesarwani, Amir A Al-Khami, Gina Scurti, et al.
Breast Cancer Research and Treatment|February 26, 2011
Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancerRoisin M Connolly, Michelle A Rudek, Elizabeth Garrett-Mayer, et al.
Cancer Research|April 12, 2018
Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8<sup>+</sup> T CellsC Bryce Johnson, Bennett R May, Brian P Riesenberg, et al.
Cancer|April 20, 2022
Attention to diet, exercise, and weight in oncology care: Results of an American Society of Clinical Oncology national patient surveyJennifer A Ligibel, Lori J Pierce, Catherine M Bender, et al.
Carcinogenesis|March 10, 2007
Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breastBrian S Cornblatt, Lingxiang Ye, Albena T Dinkova-Kostova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancerRichard C Zellars, Vered Stearns, Deborah Frassica, et al.
Pageof 33

Showing results (241-250 of 330) with videos related to

Sort By:
Pageof 33
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Pharmacodynamic-guided modified continuous reassessment method-based, dose-finding study of rapamycin in adult patients with solid tumorsAntonio Jimeno, Michelle A Rudek, Peter Kulesza, et al.
Pigment Cell & Melanoma Research|July 17, 2018
Molecular properties of gp100-reactive T-cell receptors drive the cytokine profile and antitumor efficacy of transgenic host T cellsJonathan M Eby, Angela R Smith, Timothy P Riley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2025
Promoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists: ASCO Recommendations for Academic Medical CentersEric P Winer, Laura A Levit, Ethan Basch, et al.
JCO Oncology Advances|February 5, 2025
State of Professional Well-Being, Satisfaction, and Career Plans Among US Oncologists in 2023Caroline Schenkel, Laura A Levit, Kelsey Kirkwood, et al.
Cancer Research|August 29, 2014
Promoting thiol expression increases the durability of antitumor T-cell functionsPravin Kesarwani, Amir A Al-Khami, Gina Scurti, et al.
Breast Cancer Research and Treatment|February 26, 2011
Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancerRoisin M Connolly, Michelle A Rudek, Elizabeth Garrett-Mayer, et al.
Cancer Research|April 12, 2018
Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8<sup>+</sup> T CellsC Bryce Johnson, Bennett R May, Brian P Riesenberg, et al.
Cancer|April 20, 2022
Attention to diet, exercise, and weight in oncology care: Results of an American Society of Clinical Oncology national patient surveyJennifer A Ligibel, Lori J Pierce, Catherine M Bender, et al.
Carcinogenesis|March 10, 2007
Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breastBrian S Cornblatt, Lingxiang Ye, Albena T Dinkova-Kostova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancerRichard C Zellars, Vered Stearns, Deborah Frassica, et al.
Pageof 33